Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.17925/EE.2015.11.01.39 http://scihub22266oqcxt.onion/10.17925/EE.2015.11.01.39 C5819061!5819061!29632566     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Eur+Endocrinol 2015 ; 11 (1): 39-40 Nephropedia Template TP {{tp|p=29632566|t=2015. Current Challenges in the Management of Prolactinomas |pdf=|usr=}}{{29632566}} gab.com Text Current Challenges in the Management of Prolactinomas JO: Eur Endocrinol http://www.kidney.de/pget.php?&tw=1&pmid=29632566 #FOAvip Although the diagnosis of prolactinoma is often straightforward and the treatment strategy has been well defined in recent guidelines, several challenging issues persist in their management. The differential diagnosis of a large pituitary tumour with moderately elevated prolactin (PRL) concentrations is sometimes difficult, and prolonged treatment with a dopamine agonist may be inappropriate when the diagnosis of a prolactinoma is not sufficiently well substantiated. Also, timely withdrawal of dopamine agonist treatment and the remaining indications of transsphenoidal surgery are still matters of debate. Last but not least, the management of resistant or aggressive prolactinomas remains a challenge for the clinician, especially when they occur in young patients. Twit Text FOAVip Current Challenges in the Management of Prolactinomas ????Eur Endocrinol http://www.kidney.de/pget.php?&tw=1&pmid=29632566 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29632566 #FOAvip English Wikipedia <ref>{{Cite pmid|29632566}}</ref> Current Challenges in the Management of Prolactinomas #MMPMID29632566 Maiter D Eur Endocrinol 2015[Apr]; 11 (1): 39-40 PMID29632566show ga Although the diagnosis of prolactinoma is often straightforward and the treatment strategy has been well defined in recent guidelines, several challenging issues persist in their management. The differential diagnosis of a large pituitary tumour with moderately elevated prolactin (PRL) concentrations is sometimes difficult, and prolonged treatment with a dopamine agonist may be inappropriate when the diagnosis of a prolactinoma is not sufficiently well substantiated. Also, timely withdrawal of dopamine agonist treatment and the remaining indications of transsphenoidal surgery are still matters of debate. Last but not least, the management of resistant or aggressive prolactinomas remains a challenge for the clinician, especially when they occur in young patients. äCurrent Challenges in the Management of Prolactinomas (epmc).pdf DeepDyve Pubget Overpricing